Drug Profile
DJ 5 - 3SBio
Alternative Names: DJ-5Latest Information Update: 21 Apr 2022
Price :
$50
*
At a glance
- Originator Shanghai Institute of Materia Medica
- Developer 3SBio; Shanghai Institute of Materia Medica
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Renal failure
Most Recent Events
- 21 Apr 2022 Discontinued - Preclinical for Renal failure in China (unspecified route) (3SBio pipeline, April 2022)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Renal-failure in China
- 29 Oct 2013 Preclinical trials in Renal failure in China (unspecified route)